we performed a randomized , double-blind , placebo-controlled trial to assess the efficacy and safety of inosine pranobex ( isoprinosine ) [ corrected ] in the treatment of patients with human immunodeficiency virus ( hiv ) infection but without manifest acquired immunodeficiency syndrome ( aids ) .
C0022230
inosine pranobex
C0795760
isoprinosine